pattern-detail

About The Webinar

While COVID-19 is projected to decrease global trade volumes by 13 to 30 percent this year, trade flows for personal protective equipment have grown exponentially to address urgent needs. This webinar will discuss regulatory discretion as well as restrictions that U.S. Customs and Border Protection and its partner government agencies have been exercising and considering on PPE imports in light of the crisis. 

Key Topics

  • delayed duty and revenue collection or payment
  • bond insufficiencies and collateral
  • refunds for MFN duties and section 232/301 tariff exclusions
  • response times for CBP and PGA inquiries, notices, and protests
  • CBP late payment and other enforcement claims
  • PPE emergency use authorizations and enforcement policies
  • medical device listing and registration exceptions
  • export of FEMA scarce or threatened PPE
  • PGA documentation presentation
  • cargo diversion, transit, and filing timeframes
  • inspections and requests for redelivery
  • CBP,  PGA, and other information resources

Please note we do not accept payment via American Express.

Speakers

Domenic J. Veneziano

Independent FDA Regulatory and Strategic Consultant
202-734-3939 dveneziano@strtrade.com

Lenny P. Feldman

Member
305-894-1011 lfeldman@strtrade.com

LENNY FELDMAN is a Member of Sandler, Travis & Rosenberg, P.A., resident in the Miami office and a member of the firm's Operating Committee. He previously co-chaired the twenty-member Customs and Border Protection’s Commercial Customs Operations Advisory Committee, providing strategic recommendations directly to CBP, Homeland Security and Treasury executives on issues such as forced labor, intellectual property rights, e-commerce policy, trade partnership programs, enforcement and facilitation mechanisms, and regulatory reform. He currently serves as General Counsel and Customs Counsel to the National Customs Brokers & Freight Forwarders Association of America (NCBFAA).

305-894-1011 lfeldman@strtrade.com

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.